Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet
Manufacturer
Jubilant Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Dosage Form
Tablet
Introduction
Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
How it works
Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Vogs GM 1mg/500mg/0.3mg Tablet
Sazovia GM 1mg/500mg/0.3mg Tablet
Cognipride MV 1mg/500mg/0.3mg Tablet
Giobose MV Forte 1mg/500mg/0.3mg Tablet
Glimify-MV 1 Tablet
Glimsat MV 1mg/500mg/0.3mg Tablet
Asorin MV 1mg/500mg/0.3mg Tablet
Ecovog GM 1mg/500mg/0.3mg Tablet
Gliminyle MV 1 Plus Tablet
Trivobit Forte 1mg/500mg/0.3mg Tablet
Frequently asked questions
What is Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet?
Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet is a combination of three medications: Glimepiride, Metformin and Voglibose. This medicine is used for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for Type 1 DM treatment.
What are possible side effects of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet?
Common side effects associated with Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions under which Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet should not be taken?
Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet use is avoided in patients with known allergy to any of its components or excipients. It's also avoided in those with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet?
No, alcohol should not be consumed while taking Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It is more likely to happen if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications along with it. Regular monitoring of blood sugar levels is crucial.
What are the instructions for the storage and disposal of Jubiglim MV1 Plus 1mg/500mg/0.3mg Tablet?
Store this medicine in its original package or container, tightly closed. Store according to the label's instructions. Discard unused medication. Ensure it is not consumed by pets, children, or others.
